Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: Study design of the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events post-acute cOroNary sYndromes (SYMPHO...

  • L.Kristin Newby
  • American Heart Journal, August 1999, Elsevier
  • DOI: 10.1016/s0002-8703(99)70104-3

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1016/s0002-8703(99)70104-3